Novo Nordisk
-
GLP-1 drugs are driving higher sales for Eli Lilly and Novo NordiskSales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.HealthAug 5
-
Novo Nordisk says generic Ozempic, Wegovy will slow sales in CanadaNovo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.HealthFeb 4
-
-
Advertisement
-
Health Canada approves 1st GLP-1 daily pill. Here’s who can take itThe once-a-day semaglutide pill is approved for reducing the risk of heart disease and Type 2 diabetes, the company said in a statement Monday.CanadaJan 12
-
-
Advertisement
-
Wegovy weight loss pill is now available for sale in U.S.The pill was approved by the U.S. Food and Drug Administration last month, a boon to Novo Nordisk as it looks to regain ground lost to U.S. rival Eli Lilly.HealthJan 6
-
U.S. FDA approves Wegovy weight-loss pill in industry firstThe approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly.HealthDec 22, 2025
-
-
Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talksNegotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.HealthDec 3, 2025
-
-
Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuringOzempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.WorldSep 10, 2025
-
Ozempic, Wegovy shortages are resolved in the U.S.: FDAThe drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.HealthFeb 21, 2025
-
-
Advertisement
-
Wegovy approved in Canada to combat risk of non fatal-heart attackHealth Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.HealthNov 27, 2024
-
-
Advertisement
-
Wegovy set to launch in Canada. What to know about the weight-loss drugWegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.HealthMay 2, 2024
Trending
-
-
Bidding war for Telus expected, analysts say, as Quebecor calls out Bell
3,322 READ -
Fiona the hippo dead days after ingesting knitted hat, zoo says
1,920 READ -
Secularism to pass Christianity as main group in Canada by 2050: Pew
1,711 READ -
Health Canada approves new Eli Lilly GLP-1 pill for weight loss
1,497 READ
Top Videos
-
Potential mega-merger: Why Quebecor wants to buy Telus for $31B109 Viewed -
Can a vibration plate help a hippo that swallowed a hat at the Cincinnati Zoo?94 Viewed -
Man dead, several injured after fatal rollercoaster incident at Six Flags Over Georgia54 Viewed -
Rubio says there’s ‘no evidence’ that major U.S. tech outages are connected45 Viewed -
Global National: Nov. 1944 Viewed -
Knife-wielding man holds 13-year-old girl hostage in Russia37 Viewed -